1,053
Participants
Start Date
May 6, 2020
Primary Completion Date
December 31, 2023
Study Completion Date
December 31, 2023
The sequential therapy
Proton pump inhibitors and amoxicillin for the first 5 or 7 days and sequent proton pump inhibitors, clarithromycin, and metronidazole for the next 5 or 7 days
The triple therapy
Proton pump inhibitors, amoxicillin, and clarithromycin for 7, 10, or 14 days.
The hybrid therapy
Proton pump inhibitors and amoxicillin starting from the 1st day and for a total of 10 or 14 days, and clarithromycin, and metronidazole starting from the 8th day and for a total of 7 days .
The concomitant therapy
Proton pump inhibitors, amoxicillin, clarithromycin, and metronidazole for a total of 7 or 14 days
Bismuth-based quadruple therapy
Proton pump inhibitors, bismuth, tetracycline, and metronidazole for a total of 10 or 14 days
Helicobacter pylori study group, National Cheng Kung University Hospital, Tainan City
National Cheng Kung University Hospital, Tainan City
Ministry of Health and Welfare, Taiwan
OTHER_GOV
National Cheng-Kung University Hospital
OTHER